ALBUQUERQUE – May 3, 2017 – Two new general surgeons have joined the ranks at Lovelace Medical Group. Timothy W. Perez, M.D., M.P.H. is currently accepting patients at Lovelace Medical Group’s clinic at St. Joseph Square. David Hoang, M.D. will join Lovelace Medical Group in July, 2017 as the only surgical intensivist in the practice.
ALBUQUERQUE – April 25, 2017 – Lovelace Health System was this week named one of the nation’s 15 Top U.S. health systems by Truven Health Analytics®, part of the IBM Watson HealthTM business. Truven Health Analytics is a leading provider of information and solutions to improve the cost and quality of healthcare.
ALBUQUERQUE, April 24, 2017 - Women with certain types of early-stage breast cancer now have a new treatment option available at. Lovelace Women’s Hospital is the first hospital in New Mexico that has begun providing radiotherapy using the ZEISS INTRABEAM intraoperative radiotherapy (IORT) system.
This may be an excellent therapy option for women having breast-conserving surgery, also known as a lumpectomy, according to Calvin Ridgeway, M.D., surgical oncologist at Lovelace Women’s Hospital Breast Care Center.
ALBUQUERQUE – April 13, 2017 – Lovelace Health System has announced Lovelace Medical Group Independence Square, a new two-story, 43,200 sq ft clinic at 6701 Jefferson St NE, will open for patients on April 17.
As a state-of-the-art primary care office, the new building’s design will provide for a collaborative, team-based care approach, while ensuring efficient operations. Furthermore, the design is focused on ensuring an outstanding patient experience in a modern, environmentally conscious and comfortable space.
Lovelace Health System recently hired the 32 employees of Hematology Oncology Associates of New Mexico as part of their expanding cancer care services. The Albuquerque Journal covered the story on April 4, 2017.
ALBUQUERQUE – April 4, 2017 – Lovelace Medical Center has entered into an employment agreement with Hematology Oncology Associates of New Mexico to employ all providers and staff as part of the Lovelace Cancer Center.
ALBUQUERQUE – April 3, 2017 – Steven Henao, M.D., chief vascular surgeon of New Mexico Heart Institute performed the first implant of the Ovation Alto™ Abdominal Stent Graft system in a patient on Thursday, March 30 at Heart Hospital of New Mexico at Lovelace Medical Center.
The Ovation Alto is manufactured by Endologix Corporation and is designed to treat abdominal aortic aneurysm (AAA).